On this count, long-term returns for IPOs do not boast of anything special, with most of them putting up mediocre performance. Therefore, many IPOs slip post listing because their pricing left little on the table for long-term investors. Recent IPOs such as those of Tatva Chintan Pharma, GR Infraprojects or Zomato have seen exuberant listing, with listing day gains of close to or over 100%. But even if IPOs don’t correct, that does not mean there are no investment opportunities. The more recent crop of IPOs – those that have come over the past couple of years – have certainly offered slightly more differentiated opportunities.

Source: The Hindu August 08, 2021 16:52 UTC